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PPMI. PPMI defined as 3-fold increase in CK-MB or troponin-I after procedure and
patients initially diagnosed with MI excluded.
Results: In multivariate analysis, the independent predictors for PPMI after bifurcation
stenting were acute closure in side branch, unstable angina, more than 30mm in total
stent length of parent vessel (PV), left main or 3 vessel disease, and Taxus® in PV
(HR=4.177; 95% CI=1.993-8.756, HR=2.283; 95% CI=1.581-3.297; HR=1.035; 95%
CI=1.014-1.057, HR=1.759; 95% CI=1.220-2.535 and HR=1.717; 95% CI=1.194-
2.468 respectively). During 22-month follow-up, there was no difference in mortality
between PPMI and no PPMI group (96.3% vs. 98.7%, p=0.168). Propensity score-
adjusted Cox regression analysis showed that the PPMI was not an independent
predictor of mortality (adjusted HR 0.749; 95% CI 0.166 – 3.648, p=0.777).
Kaplan-Meier curves for long-term mortality among no PPMI group, those with CK-
MB or Tn-I increase 3 to 10 times, and with CK-MB or Tn-I increase ≥10 times
Conclusion: In the bifurcation stenting, although PPMI is still occurred frequently,
however, it isn’t significantly associated with long-term mortality.
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Background: The provisional approach has become the default strategy in bifurcation
PCI. However, there are some inherent limitations of the provisional approach
including the acceptance of a suboptimal result at the side branch (SB) and the risk of
SB compromise or even occlusion. A dedicated SB stent may overcome some of these
limitations of provisional stenting by facilitating the procedure. However, there are
limited data to support this approach
Methods: We performed a retrospective cross-sectional survey of the current practice
of provsional stenting for the bifurcation. The survey collected procedural data of 110
bifurcations most recently treated with a provsional approach in 4 centres. We then
compared these data with patients enrolled in the multi-centre European registry of
true bifurcations treated with Sideguard (Cappella Inc., Galway, Ireland) dedicated
side branch stent. The primary endpoint of the study was SB failure defined as: residual
SB stenosis≥50%; inability to re-access the SB after main branch (MB) treatment;
dissection of the SB; and need for cross-over to SB stenting.
Results: Almost all lesions treated were true bifurcations in both the provisional and
Sideguard groups (97% vs. 96%). Procedural success was high in both groups (97%
vs. 96%). In the provisional group, the SB was stented in 15% of cases and 22% had
a SB residual stenosis≥50% at the end of the procedure. The primary endpoint of SB
failure occurred significantly more frequently in the provisional group (33% vs. 5%;
p=0.01). Procedural (78±23 vs. 67±29 mins; p=NS) and flouroscopy time (21.2±8.9
vs. 22+/-5.5; p=NS) were similar in both groups.
Conclusion: SB ostial protection with the Sideguard device reduces SB failure in
comparison to provisional stenting without increasing procedural time. The Sideguard
dedicated bifurcation stent could facilitate bifurcation PCI and make the procedure
more predictable and safe. This approach requires further evaluation in a randomized
controlled trial.
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Background: Provisional stenting is now the default approach for treatment of
bifurcation lesions. It is however still controversial whether dilatation of the Side
Branch (SB) after Main Vessel (MV) stenting is beneficial and when Kissing Balloon
(KB) inflation should be performed.
Methods: Optimisation using final KB technique was compared with a simpler
sequential 2 step SB-MV dilatation without kiss in a series of drug eluting stents (n=26)
delivered in a bench model of a representative coronary bifurcation. Stent apposition
and stent area was quantified at different locations along the MV from micro-CT scans.
Vessel wall stresses and detailed reconstruction of blood flow patterns were obtained
in the model using Finite Element Analysis (FEA) and Computational Fluid Dynamics
(CFD).
Results: SB ostial stenosis was on average 20.9 ± 8.7 % after KB and 25.6 ± 11.6 %
after 2-Step sequential optimization (p=0.25, ns) compared to 69.2 ± 7.8 % without
SB dilatation, p<0.0001. Differences were observed between the stent platforms with
CoCr and PtCr stents producing higher ostial stenosis than SS based platforms
(respectively 27.3 ± 8.5% and 20.0 ± 10.2%, p=0.06). KB induced a significant
asymmetric expansion of the lumen proximal to the SB and led to a higher risk of
incomplete stent apposition at the proximal stent edge (36.4 ± 29.8 % vs. 3.8 ± 10.1 %
for 2-step, p=0.0016). SB dilatation alone without further MV post-dilatation is
associated distortion of the stent at the MV ostium, resulting in a high risk of stent
malapposition opposite the SB. Rate of malapposition in the bifurcation after KB and
2-Step was respectively 22.1 ± 8.9 % and 26.6 ± 8.9 %, a significant reduction
compared to SB dilatation (55.3 ± 16.8 %, p<0.0001) or MV stenting only (47.0 ± 8.5
%, p<0.0005).
Conclusion: Sequential 2-step post-dilatation of the SB and MV may be a suitable
alternative to final Kissing Balloon Inflation after provisional stenting of bifurcations.
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Background: Treatment of coronary bifurcation lesion by drug eluting stent (DES)
reduced the restenosis and major adverse cardiac events compared to by bare metal
stent (BMS). Several study evaluated the tissue formation on the jailed strut at follow-
up term post-DES implant by OCT. The serial change of jailed struts at long-term after
implantation has not been clarified. The aim of this study was to evaluate serial change
of tissue formation at bifurcation lesions.
Methods: 20 true coronary bifurcation lesions treated with sirolimus eluting stent
(SES) were analyzed by serial optical coherence tomography (OCT) follow-up at 6
month and very late phase (43 to 73 months). We evaluated stent apposition and
coverage of neointimal tissue on the strut. Thickness of neointima were measured for
apposed strut, jailed strut and thickness of tissue surrounding jailed strut. The change
of thrombus formation was also assessed.
Results: Neointimal thickness of non-jailed (well-apposed) strut increased from 6-
month to very late phase, and on jailed strut, both neointimal tissue thickness
(67.0±49.2 to 114.0±64.9μm, P<0.05) and whole tissue thickness (332.0±165.8 to
430.7±138.3μm, P<0.05) increased. %uncovered strut at bifurcation lesion were
decreased (7.5±7.7% to 4.1±5.6%, P<0.05). The frequency of thrombus on jailed struts
at 6 months were 40% (8/20) lesions, which disappeared at very late phase.
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